275 related articles for article (PubMed ID: 34693452)
1. Identification of lipid metabolism-related genes as prognostic indicators in papillary thyroid cancer.
Wen S; Luo Y; Wu W; Zhang T; Yang Y; Ji Q; Wu Y; Shi R; Ma B; Xu M; Qu N
Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1579-1589. PubMed ID: 34693452
[TBL] [Abstract][Full Text] [Related]
2. A Metabolic-associated Nomogram Predicts Recurrence Survival of Thyroid Cancer.
Xi ZH; Ma XX; Chen HY; Yu YH; Li L; Huang T
Curr Med Sci; 2021 Oct; 41(5):1004-1011. PubMed ID: 34510328
[TBL] [Abstract][Full Text] [Related]
3. A Potential Nine-lncRNAs Signature Identification and Nomogram Diagnostic Model Establishment for Papillary Thyroid Cancer.
Yao JM; Zhao JY; Lv FF; Yang XB; Wang HJ
Pathol Oncol Res; 2022; 28():1610012. PubMed ID: 35280112
[TBL] [Abstract][Full Text] [Related]
4. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
5. Transcriptome Analyses Identify a Metabolic Gene Signature Indicative of Dedifferentiation of Papillary Thyroid Cancer.
Ma B; Jiang H; Wen D; Hu J; Han L; Liu W; Xu W; Shi X; Wei W; Liao T; Wang Y; Lu Z; Wang Y; Ji Q
J Clin Endocrinol Metab; 2019 Sep; 104(9):3713-3725. PubMed ID: 30942873
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA signature predicts survival in papillary thyroid carcinoma.
Chengfeng X; Gengming C; Junjia Z; Yunxia L
J Cell Biochem; 2019 Oct; 120(10):17050-17058. PubMed ID: 31099134
[TBL] [Abstract][Full Text] [Related]
7. Identification of iron metabolism-related genes as prognostic indicators for papillary thyroid carcinoma: a retrospective study.
Jin T; Ge L; Chen J; Wang W; Zhang L; Ge M
PeerJ; 2023; 11():e15592. PubMed ID: 37361050
[TBL] [Abstract][Full Text] [Related]
8. An 8 miRNA-Based Risk Score System for Predicting the Prognosis of Patients With Papillary Thyroid Cancer.
Yi W; Liu J; Qu S; Fan H; Lv Z
Technol Cancer Res Treat; 2020; 19():1533033820965594. PubMed ID: 33054579
[TBL] [Abstract][Full Text] [Related]
9. IGFBP3 as an indicator of lymph node metastasis and unfavorable prognosis for papillary thyroid carcinoma.
Huang Y; Chang A; Zhou W; Zhao H; Zhuo X
Clin Exp Med; 2020 Nov; 20(4):515-525. PubMed ID: 32596748
[TBL] [Abstract][Full Text] [Related]
10. A new ferroptosis-related gene model for prognostic prediction of papillary thyroid carcinoma.
Qian X; Tang J; Li L; Chen Z; Chen L; Chu Y
Bioengineered; 2021 Dec; 12(1):2341-2351. PubMed ID: 34077308
[TBL] [Abstract][Full Text] [Related]
11. OGDHL closely associates with tumor microenvironment and can serve as a prognostic biomarker for papillary thyroid cancer.
Mao M; Huang RZ; Zheng J; Liang HQ; Huang WH; Liu J; Li JH
Cancer Med; 2021 Jan; 10(2):728-736. PubMed ID: 33405394
[TBL] [Abstract][Full Text] [Related]
12. Identification of a Five-Gene Signature and Establishment of a Prognostic Nomogram to Predict Progression-Free Interval of Papillary Thyroid Carcinoma.
Wu M; Yuan H; Li X; Liao Q; Liu Z
Front Endocrinol (Lausanne); 2019; 10():790. PubMed ID: 31803141
[No Abstract] [Full Text] [Related]
13. Bioinformatics analysis of the prognostic and clinical value of senescence-related gene signature in papillary thyroid cancer.
Wen T; Guo S
Medicine (Baltimore); 2023 Jun; 102(22):e33934. PubMed ID: 37266618
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide scanning for CHD1L gene in papillary thyroid carcinoma complicated with type 2 diabetes mellitus.
Kang YY; Li JJ; Sun JX; Wei JX; Ding C; Shi CL; Wu G; Li K; Ma YF; Sun Y; Qiao H
Clin Transl Oncol; 2021 Dec; 23(12):2536-2547. PubMed ID: 34245428
[TBL] [Abstract][Full Text] [Related]
15. GADD45B Transcript Is a Prognostic Marker in Papillary Thyroid Carcinoma Patients Treated With Total Thyroidectomy and Radioiodine Therapy.
Barros-Filho MC; de Mello JBH; Marchi FA; Pinto CAL; da Silva IC; Damasceno PKF; Soares MBP; Kowalski LP; Rogatto SR
Front Endocrinol (Lausanne); 2020; 11():269. PubMed ID: 32425887
[TBL] [Abstract][Full Text] [Related]
16. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
17. BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis.
Zhang C; Bo C; Guo L; Yu P; Miao S; Gu X
World J Surg Oncol; 2019 Dec; 17(1):221. PubMed ID: 31842912
[TBL] [Abstract][Full Text] [Related]
18. A Potential Four-Gene Signature and Nomogram for Predicting the Overall Survival of Papillary Thyroid Cancer.
Ding Y; Li P; Wang W; Liu F
Dis Markers; 2022; 2022():8735551. PubMed ID: 36193505
[TBL] [Abstract][Full Text] [Related]
19. Tumor Mutation Burden Predicts Relapse in Papillary Thyroid Carcinoma With Changes in Genes and Immune Microenvironment.
Guo M; Chen Z; Li Y; Li S; Shen F; Gan X; Feng J; Cai W; Liu Q; Xu B
Front Endocrinol (Lausanne); 2021; 12():674616. PubMed ID: 34248843
[TBL] [Abstract][Full Text] [Related]
20. Golgi-apparatus genes related signature for predicting the progression-free interval of patients with papillary thyroid carcinoma.
Liu R; Cao Z; Wu M; Li X; Fan P; Liu Z
BMC Med Genomics; 2023 Mar; 16(1):60. PubMed ID: 36973751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]